LAG3 Peptide

• NCBI Gene ID :

  3902

• Swiss Prot :

  P18627

• Accession Number :

  NP_002277

• Type :

  Peptides

• Concentration :

  200 ug/mL

• Buffer :

  PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  Store LAG3 peptide at -20˚ C, stable for one year.

• Applications Notes :

  LAG3 peptide is used for blocking the activity of LAG3 antibody.

• NCBI Official Name :

  Lymphocyte activating 3

• NCBI Organism :

  Homo sapiens

• Background Reference 01 :

  Huard B, Tournier M, Hercend T, et al. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes. Eur J Immunol 1994; 24:3216–21.

• Background Reference 02 :

  Triebel F. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol 2003; 24:619–22.

• Background Reference 03 :

  Workman CJ, Wang Y, El Kasmi KC, et al. LAG-3 regulates plasmacytoid dendritic cell homeostasis. J Immunol. 2009; 182:1885–91.

• Background Reference 04 :

  Workman CJ, Vignali DA. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 2003; 33:970–9.

• Other Product Names :

  Lymphocyte activating 3, LAG-3, CD223

• Tested Applications :

  Blocking

• Species :

  Human

• Protein ID :

  167614500

• Physical Properties :

  Liquid